Literature DB >> 15812448

Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002.

Vincent C Smith1, John A F Zupancic, Marie C McCormick, Lisa A Croen, John Greene, Gabriel J Escobar, Douglas K Richardson.   

Abstract

OBJECTIVE: To examine temporal trends in the rates of severe bronchopulmonary dysplasia (BPD) between 1994 and 2002. STUDY
DESIGN: In a retrospective cohort study, all infants with a gestational age (GA) <33 weeks in a large managed care organization were identified. Annual rates of BPD (defined as an oxygen requirement at 36 weeks corrected GA), severe BPD (defined as respiratory support at 36 weeks corrected GA), and death before 36 weeks corrected GA were examined.
RESULTS: Of the 5115 infants in the study cohort, 603 (12%) had BPD, including 246 (4.9%) who had severe BPD. There were 481 (9.5%) deaths before 36 weeks corrected GA. Although the decline in BPD in this period was not significant, the rates of severe BPD declined from 9.7% in 1994 to 3.7% in 2002. Controlling for gestational age, the odds ratio (95% CI) for annual rate of decline in severe BPD was 0.890 (0.841-0.941). Controlling for gestational age, deaths before 36 weeks corrected GA also declined, with the odds ratio (CI) for the annual decline being 0.944 (0.896-0.996).
CONCLUSIONS: In this study population, the odds of having of BPD remained constant after controlling for GA. However, the odds of having severe BPD declined on average 11% per year between 1994 and 2002.

Entities:  

Mesh:

Year:  2005        PMID: 15812448     DOI: 10.1016/j.jpeds.2004.12.023

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  44 in total

1.  RSV infection in prematurely born infants.

Authors:  S Deshpande
Journal:  Thorax       Date:  2006-06       Impact factor: 9.139

Review 2.  Pathogenesis and treatment of bronchopulmonary dysplasia.

Authors:  Jason Gien; John P Kinsella
Journal:  Curr Opin Pediatr       Date:  2011-06       Impact factor: 2.856

Review 3.  Chronic lung disease in newborns.

Authors:  M Jeeva Sankar; Ramesh Agarwal; Ashok K Deorari; Vinod K Paul
Journal:  Indian J Pediatr       Date:  2008-05-18       Impact factor: 1.967

4.  Refractory pulmonary hypertension following extremely preterm birth: paradoxical improvement in oxygenation after atrial septostomy.

Authors:  Hiroki Saitsu; Osuke Iwata; Junichiro Okada; Akiko Hirose; Hiroshi Kanda; Toyojiro Matsuishi; Kenji Suda; Yasuki Maeno
Journal:  Eur J Pediatr       Date:  2013-08-03       Impact factor: 3.183

5.  Serum neurotrophins at birth correlate with respiratory and neurodevelopmental outcomes of premature infants.

Authors:  Samantha L Simpson; Stephanie Grayson; Jennifer H Peterson; John J Moore; Maroun J Mhanna; Miriam K Perez; Fariba Rezaee; Giovanni Piedimonte
Journal:  Pediatr Pulmonol       Date:  2018-12-21

6.  The renin angiotensin system in liver and lung: impact and therapeutic potential in organ fibrosis.

Authors:  Amal Abdul-Hafez; Tarek Mohamed; Hanan Omar; Mohamed Shemis; Bruce D Uhal
Journal:  J Lung Pulm Respir Res       Date:  2018-02-27

7.  Developmental determinants and changing patterns of respiratory outcomes after preterm birth.

Authors:  Steven H Abman; Simon J Conway
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-03

8.  Chronic lung disease in preterm lambs: effect of daily vitamin A treatment on alveolarization.

Authors:  Kurt H Albertine; Mar Janna Dahl; Linda W Gonzales; Zheng-Ming Wang; Drew Metcalfe; Dallas M Hyde; Charles G Plopper; Barry C Starcher; David P Carlton; Richard D Bland
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-04-09       Impact factor: 5.464

9.  Up-date on the NeoVitaA Trial: Obstacles, challenges, perspectives, and local experiences.

Authors:  Sascha Meyer; Ludwig Gortner
Journal:  Wien Med Wochenschr       Date:  2016-09-26

Review 10.  Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia.

Authors:  Vineet Bhandari
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.